🚀 Pharmidex at BioWednesday Stevenage 🚀
February 5, 2025
We are excited to share that our Business Development Manager, Janette Dalay Robertson, and Head of Operations,
Ash Alavijeh, had the pleasure of attending the BioWednesday Stevenage: Key Messages and Sentiments from JPM Week 2025 event today at the
Stevenage Bioscience Catalyst.
It was a fantastic opportunity to connect with industry leaders, potential clients, and partners. Janette and Ash were thrilled to engage in meaningful conversations, exploring new collaborations, and discussing the latest insights from JPM Week 2025.
At Pharmidex, we're committed to expanding our relationships and helping our clients navigate their path to success in drug discovery and development. Together, we’re working towards creating a healthier future.
A big thank you to everyone we had the pleasure of meeting today. We look forward to the continued conversations and collaborations!
#Pharmidex #BioWednesday #JPMWeek2025 #DrugDiscovery #Biotech #Innovation #Pharmaceuticals #Networking #StevenageBioScienceCatalyst
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
